Shimadzu Goes Direct in Malaysia

Shimadzu Corporation has established Shimadzu Malaysia Sdn Bhd, an indirectly-owned subsidiary, to further strengthen its capabilities in the India subcontinent and ASEAN region, which have shown remarkable economic growth in recent years and are projected to continue growing in the future.

This new company is a wholly-owned subsidiary of Shimadzu (Asia Pacific) Pte Ltd, abbreviated below as SAP. Shimadzu Corporation also plans to establish a new manufacturing facility for Analytical and Measuring instruments and an in-house Application Laboratory, in order to strengthen manufacturing, sales and application support capabilities. Construction on the new plant is scheduled to start in October 2015 and finish in July 2016, with operations starting in December 2016.
 

Previously, analytical and measuring instrument sales in Malaysia were conducted through Shimadzu's local distributors. However, this newly established local subsidiary of Shimadzu will now provide direct sales and service capabilities. While starting direct sales of analytical instruments, such as High-Performance Liquid Chromatographs (HPLCs), to markets such as food products, pharmaceuticals, and petrochemical, Shimadzu will continue to rely on the expertise of local distributors for sales of X-ray Fluorescence spectrometers, optical emission spectrometers, X-ray diffractometers, testing machines, and non-destructive inspection systems. This will not only help in maximising customer convenience but will also help to further build the brand image of Shimadzu.

Consequently, SAP's Malaysian branch office, which was established in 2000 for direct sales of medical equipment, will be merged and integrated into the new subsidiary as its medical systems department. Shimadzu has earned a strong reputation in Malaysia for the quality and extensive service of Shimadzu X-ray systems, which has resulted in the organisation securing a 25% market share, with over 50% of the market for general-purpose X-ray systems sold to hospitals. Shimadzu now intends to strengthen efforts to sell more high-end Angiography systems and develop the clinic market.